15 million COVID-19 vaccine doses wasted in U.S. since March 1
Sep 02, 2021
Reasons why doses may be marked as wasted include a cracked vial, an error diluting the vaccine or a freezer malfunction.
CDC calls emergency meeting on heart inflammation link to COVID-19 vaccines
Jun 11, 2021
The agency has identified 226 reports so far that may meet its ‘working case definition’ of myocarditis and pericarditis.
Subcutaneous mAb may benefit high-risk outpatients with COVID-19
Apr 12, 2022
SC casirivimab and imdevimab were linked to reduced 28-day hospitalization or death for high-risk outpatients with mild to moderate COVID-19.
Guillain-Barré syndrome may be triggered by SARS-CoV-2 infection
Sep 24, 2021
“Our study shows that COVID-19 may precede Guillain-Barré syndrome in rare cases,” a coauthor said in a statement, “but the existence of a true association or causal relation still needs...
SARS-CoV-2 mAbs continued to be used after FDA deauthorization
Aug 30, 2022
More than 158,000 doses of bamlanivimab-etesevimab and casirivimab-imdevimab were used after deauthorization on Jan. 24, 2022.
SARS-CoV-2 antibodies may persist nine months after infection
Jul 26, 2021
Antibody levels appear to remain positive for up to nine months after severe acute respiratory syndrome coronavirus 2 infection, according to a study published online July 19 in Nature Communications.
Food allergy tied to lower risk for SARS-CoV-2 infection
Jun 09, 2022
Asthma does not raise the risk for infection or household transmission.
Vaccination after SARS-CoV-2 infection may cut long COVID risk
May 23, 2022
An initial decrease in odds for long COVID was seen after the first vaccine dose, with evidence suggesting sustained improvement after the second dose.
Flu vaccine may protect against adverse events after SARS-CoV-2
Aug 17, 2021
Individuals who had received a flu vaccination had lower risks for sepsis, stroke and deep vein thromboses as well as emergency department and ICU admissions
New symptoms, conditions may develop after positive test for SARS-CoV-2
Feb 11, 2022
Among hospitalized patients aged 20 years or older, the prevalence of new fatigue and type 2 diabetes were up for those with a positive versus a negative SARS-CoV-2 result.